Drugs in the treatment of asthma.
D000316:Adrenergic alpha-Agonists / Q000494:pharmacology; D000318:Adrenergic beta-Agonists / Q000009:adverse effects / Q000627:therapeutic use; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000818:Animals; D001249:Asthma / Q000188:drug therapy*; D004205:Cromolyn Sodium / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D000242:Cyclic AMP / Q000378:metabolism; D004359:Drug Therapy, Combination; D005938:Glucocorticoids / Q000378:metabolism / Q000627:therapeutic use; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010276:Parasympatholytics / Q000627:therapeutic use; D011458:Prostaglandins E / Q000627:therapeutic use; D013806:Theophylline / Q000009:adverse effects / Q000031:analogs & derivatives / Q000378:metabolism / Q000627:therapeutic use
D000316:Adrenergic alpha-Agonists; D000318:Adrenergic beta-Agonists; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D007166:Immunosuppressive Agents; D010276:Parasympatholytics; D011458:Prostaglandins E; D000324:Adrenocorticotropic Hormone; D013806:Theophylline; D000242:Cyclic AMP; D004205:Cromolyn Sodium